
### [NCIT:C6796](http://purl.obolibrary.org/obo/NCIT_C6796)
**Label:** Eccrine Neoplasm

**Subclasses:** [NCIT:C27255](http://purl.obolibrary.org/obo/NCIT_C27255) (Eccrine Carcinoma), [NCIT:C5559](http://purl.obolibrary.org/obo/NCIT_C5559) (Malignant Eccrine Neoplasm), [NCIT:C3761](http://purl.obolibrary.org/obo/NCIT_C3761) (Syringoma), [NCIT:C6797](http://purl.obolibrary.org/obo/NCIT_C6797) (Benign Eccrine Neoplasm), [NCIT:C27254](http://purl.obolibrary.org/obo/NCIT_C27254) (Papillary Eccrine Carcinoma), [NCIT:C40306](http://purl.obolibrary.org/obo/NCIT_C40306) (Vulvar Eccrine Porocarcinoma), [NCIT:C7565](http://purl.obolibrary.org/obo/NCIT_C7565) (Eccrine Hidrocystoma), [NCIT:C43345](http://purl.obolibrary.org/obo/NCIT_C43345) (Ductal Eccrine Adenocarcinoma), [NCIT:C43346](http://purl.obolibrary.org/obo/NCIT_C43346) (Ductal Eccrine Carcinoma with Spindle Cell Elements), [NCIT:C40305](http://purl.obolibrary.org/obo/NCIT_C40305) (Vulvar Eccrine Adenocarcinoma), [NCIT:C43347](http://purl.obolibrary.org/obo/NCIT_C43347) (Ductal Eccrine Carcinoma with Squamous Metaplasia), [NCIT:C5560](http://purl.obolibrary.org/obo/NCIT_C5560) (Eccrine Porocarcinoma), [NCIT:C40311](http://purl.obolibrary.org/obo/NCIT_C40311) (Vulvar Syringoma), 

**Class expressions from DL-Learner:**

- [NCIT:C62495](http://purl.obolibrary.org/obo/NCIT_C62495) (Neoplastic Eccrine Cell) 56.52%
- [NCIT:C62499](http://purl.obolibrary.org/obo/NCIT_C62499) (Malignant Eccrine Cell) 54.35%
- Thing 53.90%
- [NCIT:C62497](http://purl.obolibrary.org/obo/NCIT_C62497) (Eccrine Adenocarcinoma Cell) 52.17%
- [NCIT:C39690](http://purl.obolibrary.org/obo/NCIT_C39690) (Papular Lesion) 52.17%
- [NCIT:C36877](http://purl.obolibrary.org/obo/NCIT_C36877) (Neoplastic Ductal Epithelial Cell) 52.17%
- [NCIT:C36858](http://purl.obolibrary.org/obo/NCIT_C36858) (Ductal Carcinoma Cell) 52.17%
- [NCIT:C36180](http://purl.obolibrary.org/obo/NCIT_C36180) (Multifocal Lesion) 52.17%
- [NCIT:C36117](http://purl.obolibrary.org/obo/NCIT_C36117) (Invasive Lesion) 52.17%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) 37.53%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C37223](http://purl.obolibrary.org/obo/NCIT_C37223) (PML-RARA Fusion Protein Expression))) 37.53%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C37222](http://purl.obolibrary.org/obo/NCIT_C37222) (NUMA1-RARA Fusion Protein Expression))) 37.53%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C37221](http://purl.obolibrary.org/obo/NCIT_C37221) (NPM1-RARA Fusion Protein Expression))) 37.53%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C37220](http://purl.obolibrary.org/obo/NCIT_C37220) (ZBTB16-RARA Fusion Protein Expression))) 37.53%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C37219](http://purl.obolibrary.org/obo/NCIT_C37219) (CBFB-MYH11 Fusion Protein Expression))) 37.53%


